Hemorrhagic fever viruses, including the filoviruses (Ebola and Marburg) and arenaviruses (Lassa and Junín viruses), are serious human pathogens for which there are currently no FDA approved therapeutics or vaccines. Importantly, transmission of these viruses, and specifically late steps of budding, critically depend upon host cell machinery. Consequently, strategies which target these mechanisms represent potential targets for broad spectrum host oriented therapeutics. An important cellular signal implicated previously in EBOV budding is calcium. Indeed, host cell calcium signals are increasingly being recognized to play a role in steps of entry, replication, and transmission for a range of viruses, but if and how filoviruses and arenaviruses mobilize calcium and the precise stage of virus transmission regulated by calcium have not been defined. Here we demonstrate that expression of matrix proteins from both filoviruses and arenaviruses triggers an increase in host cytoplasmic Ca2+ concentration by a mechanism that requires host Orai1 channels. Furthermore, we demonstrate that Orai1 regulates both VLP and infectious filovirus and arenavirus production and spread. Notably, suppression of the protein that triggers Orai activation (Stromal Interaction Molecule 1, STIM1) and genetic inactivation or pharmacological blockade of Orai1 channels inhibits VLP and infectious virus egress. These findings are highly significant as they expand our understanding of host mechanisms that may broadly control enveloped RNA virus budding, and they establish Orai and STIM1 as novel targets for broad-spectrum host-oriented therapeutics to combat these emerging BSL-4 pathogens and potentially other enveloped RNA viruses that bud via similar mechanisms.
References
[1]
Chen BJ, Lamb RA. Mechanisms for enveloped virus budding: can some viruses do without an ESCRT? Virology. 2008;372(2):221–32. pmid:18063004 doi: 10.1016/j.virol.2007.11.008
[2]
Hartlieb B, Weissenhorn W. Filovirus assembly and budding. Virology. 2006;344(1):64–70. pmid:16364737 doi: 10.1016/j.virol.2005.09.018
[3]
Harty RN. No exit: targeting the budding process to inhibit filovirus replication. Antiviral Res. 2009;81(3):189–97. doi: 10.1016/j.antiviral.2008.12.003. pmid:19114059
Liu Y, Harty RN. Viral and host proteins that modulate filovirus budding. Future Virol. 2010;5(4):481–91. pmid:20730024 doi: 10.2217/fvl.10.33
[6]
Urata S, de la Torre JC. Arenavirus budding. Advances in virology. 2011;2011:180326. doi: 10.1155/2011/180326. pmid:22312335
[7]
Neumann G, Ebihara H, Takada A, Noda T, Kobasa D, Jasenosky LD, et al. Ebola virus VP40 late domains are not essential for viral replication in cell culture. Journal of Virology. 2005;79(16):10300–7. pmid:16051823 doi: 10.1128/jvi.79.16.10300-10307.2005
Feldmann H, Klenk HD. Marburg and Ebola viruses. Advances in virus research. 1996;47:1–52. pmid:8895830 doi: 10.1016/s0065-3527(08)60733-2
[10]
Grant A, Seregin A, Huang C, Kolokoltsova O, Brasier A, Peters C, et al. Junin virus pathogenesis and virus replication. Viruses. 2012;4(10):2317–39. doi: 10.3390/v4102317. pmid:23202466
Lingappa UF, Wu X, Macieik A, Yu SF, Atuegbu A, Corpuz M, et al. Host-rabies virus protein-protein interactions as druggable antiviral targets. Proceedings of the National Academy of Sciences of the United States of America. 2013;110(10):E861–8. doi: 10.1073/pnas.1210198110. pmid:23404707
[13]
Adamson CS, Freed EO. Novel approaches to inhibiting HIV-1 replication. Antiviral research. 2010;85(1):119–41. doi: 10.1016/j.antiviral.2009.09.009. pmid:19782103
[14]
Aman MJ, Kinch MS, Warfield K, Warren T, Yunus A, Enterlein S, et al. Development of a broad-spectrum antiviral with activity against Ebola virus. Antiviral research. 2009;83(3):245–51. doi: 10.1016/j.antiviral.2009.06.001. pmid:19523489
[15]
Andrei G, De Clercq E. Molecular approaches for the treatment of hemorrhagic fever virus infections. Antiviral research. 1993;22(1):45–75. pmid:8250543 doi: 10.1016/0166-3542(93)90085-w
[16]
Connor JH, McKenzie MO, Parks GD, Lyles DS. Antiviral activity and RNA polymerase degradation following Hsp90 inhibition in a range of negative strand viruses. Virology. 2007;362(1):109–19. pmid:17258257 doi: 10.1016/j.virol.2006.12.026
[17]
Garcia M, Cooper A, Shi W, Bornmann W, Carrion R, Kalman D, et al. Productive Replication of Ebola Virus Is Regulated by the c-Abl1 Tyrosine Kinase. Science translational medicine. 2012;4(123):123ra24. doi: 10.1126/scitranslmed.3003500. pmid:22378924
[18]
Kinch MS, Yunus AS, Lear C, Mao H, Chen H, Fesseha Z, et al. FGI-104: a broad-spectrum small molecule inhibitor of viral infection. American journal of translational research. 2009;1(1):87–98. pmid:19966942 doi: 10.1016/j.antiviral.2009.02.082
[19]
Kolokoltsov AA, Adhikary S, Garver J, Johnson L, Davey RA, Vela EM. Inhibition of Lassa virus and Ebola virus infection in host cells treated with the kinase inhibitors genistein and tyrphostin. Archives of virology. 2012;157(1):121–7. doi: 10.1007/s00705-011-1115-8. pmid:21947546
[20]
Perez M, Craven RC, de la Torre JC. The small RING finger protein Z drives arenavirus budding: implications for antiviral strategies. Proceedings of the National Academy of Sciences of the United States of America. 2003;100(22):12978–83. pmid:14563923 doi: 10.1073/pnas.2133782100
[21]
Tavassoli A, Lu Q, Gam J, Pan H, Benkovic SJ, Cohen SN. Inhibition of HIV budding by a genetically selected cyclic peptide targeting the Gag-TSG101 interaction. ACS chemical biology. 2008;3(12):757–64. doi: 10.1021/cb800193n. pmid:19053244
[22]
Urata S, Ngo N, de la Torre JC. The PI3K/Akt Pathway Contributes To Arenavirus Budding. J Virol. 2012;86(8):4578–85. doi: 10.1128/JVI.06604-11. pmid:22345463
[23]
Warren TK, Warfield KL, Wells J, Enterlein S, Smith M, Ruthel G, et al. Antiviral activity of a small-molecule inhibitor of filovirus infection. Antimicrobial agents and chemotherapy. 2010;54(5):2152–9. doi: 10.1128/AAC.01315-09. pmid:20211898
[24]
Stathopulos PB, Li GY, Plevin MJ, Ames JB, Ikura M. Stored Ca2+ depletion-induced oligomerization of stromal interaction molecule 1 (STIM1) via the EF-SAM region: An initiation mechanism for capacitive Ca2+ entry. JBiolChem. 2006;281(47):35855–62. doi: 10.1074/jbc.m608247200
[25]
Hogan PG, Lewis RS, Rao A. Molecular basis of calcium signaling in lymphocytes: STIM and ORAI. Annu Rev Immunol. 2010;28:491–533. doi: 10.1146/annurev.immunol.021908.132550. pmid:20307213
[26]
Vig M, Peinelt C, Beck A, Koomoa DL, Rabah D, Koblan-Huberson M, et al. CRACM1 is a plasma membrane protein essential for store-operated Ca2+ entry. Science. 2006;312(5777):1220–3. pmid:16645049 doi: 10.1126/science.1127883
[27]
Feske S, Gwack Y, Prakriya M, Srikanth S, Puppel SH, Tanasa B, et al. A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature. 2006;441(7090):179–85. pmid:16582901 doi: 10.1038/nature04702
[28]
Zhang SL, Yeromin AV, Zhang XH, Yu Y, Safrina O, Penna A, et al. Genome-wide RNAi screen of Ca2+ influx identifies genes that regulate Ca2+ release-activated Ca2+ channel activity. ProcNatlAcadSciUSA. 2006;103(24):9357–62. doi: 10.1073/pnas.0603161103
[29]
Rao A. Signaling to gene expression: calcium, calcineurin and NFAT. Nat Immunol. 2009;10(1):3–5. doi: 10.1038/ni0109-3. pmid:19088731
[30]
Babich A, Burkhardt JK. Coordinate control of cytoskeletal remodeling and calcium mobilization during T-cell activation. Immunological reviews. 2013;256(1):80–94. doi: 10.1111/imr.12123. pmid:24117814
[31]
Freedman BD. Mechanisms of calcium signaling and function in lymphocytes. Critical Reviews in Immunology. 2006;26(2):97–111. pmid:16700648 doi: 10.1615/critrevimmunol.v26.i2.10
[32]
Han Z, Harty RN. Influence of calcium/calmodulin on budding of Ebola VLPs: implications for the involvement of the Ras/Raf/MEK/ERK pathway. Virus Genes. 2007;35(3):511–20. pmid:17570046 doi: 10.1007/s11262-007-0125-9
[33]
Su S, Phua SC, DeRose R, Chiba S, Narita K, Kalugin PK, et al. Genetically encoded calcium indicator illuminates calcium dynamics in primary cilia. Nature methods. 2013;10:1105–07. doi: 10.1038/nmeth.2647. pmid:24056873
[34]
Hou X, Pedi L, Diver MM, Long SB. Crystal structure of the calcium release-activated calcium channel Orai. Science. 2012;338(6112):1308–13. doi: 10.1126/science.1228757. pmid:23180775
[35]
Liou J, Kim ML, Heo WD, Jones JT, Myers JW, Ferrell JE Jr., et al. STIM is a Ca2+ sensor essential for Ca2+-store-depletion-triggered Ca2+ influx. CurrBiol. 2005;15(13):1235–41. doi: 10.1016/j.cub.2005.05.055
[36]
Roos J, DiGregorio PJ, Yeromin AV, Ohlsen K, Lioudyno M, Zhang S, et al. STIM1, an essential and conserved component of store-operated Ca2+ channel function. JCell Biol. 2005;169(3):435–45.
[37]
Zhang SL, Yu Y, Roos J, Kozak JA, Deerinck TJ, Ellisman MH, et al. STIM1 is a Ca2+ sensor that activates CRAC channels and migrates from the Ca2+ store to the plasma membrane. Nature. 2005;437(7060):902–5. pmid:16208375 doi: 10.1038/nature04147
[38]
Prakriya M, Lewis RS. Potentiation and inhibition of Ca2+ release-activated Ca2+ channels by 2-aminoethyldiphenyl borate (2-APB) occurs independently of IP(3) receptors. JPhysiol. 2001;536(Pt 1):3–19. doi: 10.1111/j.1469-7793.2001.t01-1-00003.x
[39]
Ng SW, Di CJ, Singaravelu K, Parekh AB. Sustained activation of the tyrosine kinase Syk by antigen in mast cells requires local Ca2+ influx through Ca2+ release-activated Ca2+ channels. JBiolChem. 2008;283(46):31348–55. doi: 10.1074/jbc.m804942200
[40]
Chen G, Panicker S, Lau KY, Apparsundaram S, Patel VA, Chen SL, et al. Characterization of a novel CRAC inhibitor that potently blocks human T cell activation and effector functions. Molecular immunology. 2013;54(3–4):355–67. pmid:23357789 doi: 10.1016/j.molimm.2012.12.011
[41]
Cuevas CD, Lavanya M, Wang E, Ross SR. Junin virus infects mouse cells and induces innate immune responses. Journal of virology. 2011;85(21):11058–68. doi: 10.1128/JVI.05304-11. pmid:21880772
[42]
Lu J, Han Z, Liu Y, Liu W, Lee MS, Olson MA, et al. A host-oriented inhibitor of Junin Argentine hemorrhagic fever virus egress. J Virol. 2014;88(9):4736–43. doi: 10.1128/JVI.03757-13. pmid:24522922
[43]
Ehrlich LS, Carter CA. HIV Assembly and Budding: Ca(2+) Signaling and Non-ESCRT Proteins Set the Stage. Mol Biol Int. 2012;2012:851670. doi: 10.1155/2012/851670. pmid:22761998
[44]
Ehrlich LS, Medina GN, Carter CA. ESCRT machinery potentiates HIV-1 utilization of the PI(4,5)P(2)-PLC-IP3R-Ca2+ signaling cascade. Journal of molecular biology. 2011;413(2):347–58. pmid:21875593 doi: 10.1016/j.jmb.2011.08.038
[45]
Wang J, Peng Q, Lin Q, Childress C, Carey D, Yang W. Calcium activates Nedd4 E3 ubiquitin ligases by releasing the C2 domain-mediated auto-inhibition. J Biol Chem. 2010;285(16):12279–88. doi: 10.1074/jbc.M109.086405. pmid:20172859
[46]
Bissig C, Lenoir M, Velluz M-CC, Kufareva I, Abagyan R, Overduin M, et al. Viral infection controlled by a calcium-dependent lipid-binding module in ALIX. Developmental cell. 2013;25(4):364–73. doi: 10.1016/j.devcel.2013.04.003. pmid:23664863
[47]
Maki M, Suzuki H, Shibata H. Structure and function of ALG-2, a penta-EF-hand calcium-dependent adaptor protein. Sci China Life Sci. 2011;54(8):770–9. doi: 10.1007/s11427-011-4204-8. pmid:21786200
[48]
Scheffer LL, Sreetama SC, Sharma N, Medikayala S, Brown KJ, Defour A, et al. Mechanism of Ca2+-triggered ESCRT assembly and regulation of cell membrane repair. Nat Commun. 2014;5:5646. doi: 10.1038/ncomms6646. pmid:25534348
[49]
Hyser JM, Utama B, Crawford SE, Broughman JR, Estes MK. Activation of the endoplasmic reticulum calcium sensor STIM1 and store-operated calcium entry by rotavirus requires NSP4 viroporin activity. Journal of virology. 2013;87(24):13579–88. doi: 10.1128/JVI.02629-13. pmid:24109210
[50]
Siddharthan V, Wang H, Davies CJ, Hall JO, Morrey JD. Inhibition of west nile virus by calbindin-D28k. PLoS One. 2014;9(9):e106535. doi: 10.1371/journal.pone.0106535. pmid:25180779
[51]
Scherbik SV, Brinton MA. Virus-induced Ca2+ influx extends survival of west nile virus-infected cells. J Virol. 2010;84(17):8721–31. doi: 10.1128/JVI.00144-10. pmid:20538858
[52]
de Jong AS, Visch HJ, de Mattia F, van Dommelen MM, Swarts HG, Luyten T, et al. The coxsackievirus 2B protein increases efflux of ions from the endoplasmic reticulum and Golgi, thereby inhibiting protein trafficking through the Golgi. J Biol Chem. 2006;281(20):14144–50. pmid:16540472 doi: 10.1074/jbc.m511766200
[53]
van Kuppeveld FJ, Hoenderop JG, Smeets RL, Willems PH, Dijkman HB, Galama JM, et al. Coxsackievirus protein 2B modifies endoplasmic reticulum membrane and plasma membrane permeability and facilitates virus release. EMBO J. 1997;16(12):3519–32. pmid:9218794 doi: 10.1093/emboj/16.12.3519
[54]
Yang B, Bouchard MJ. The hepatitis B virus X protein elevates cytosolic calcium signals by modulating mitochondrial calcium uptake. J Virol. 2012;86(1):313–27. doi: 10.1128/JVI.06442-11. pmid:22031934
[55]
Dellis O, Arbabian A, Papp B, Rowe M, Joab I, Chomienne C. Epstein-Barr virus latent membrane protein 1 increases calcium influx through store-operated channels in B lymphoid cells. J Biol Chem. 2011;286(21):18583–92. doi: 10.1074/jbc.M111.222257. pmid:21454636
[56]
Dellis O, Arbabian A, Brouland JP, Kovacs T, Rowe M, Chomienne C, et al. Modulation of B-cell endoplasmic reticulum calcium homeostasis by Epstein-Barr virus latent membrane protein-1. Molecular cancer. 2009;8:59. doi: 10.1186/1476-4598-8-59. pmid:19650915
[57]
Lavanya M, Cuevas CD, Thomas M, Cherry S, Ross SR. siRNA screen for genes that affect Junín virus entry uncovers voltage-gated calcium channels as a therapeutic target. Science translational medicine. 2013;5(204). doi: 10.1126/scitranslmed.3006827
[58]
Grissmer S, Nguyen AN, Aiyar J, Hanson DC, Mather RJ, Gutman GA, et al. Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines. MolPharmacol. 1994;45(6):1227–34.
[59]
Verheugen JA, Korn H. A charybdotoxin-insensitive conductance in human T lymphocytes: T cell membrane potential is set by distinct K+ channels. JPhysiol (Lond). 1997;503 (Pt 2):317–31. doi: 10.1111/j.1469-7793.1997.317bh.x
[60]
Freedman BD, Price MA, Deutsch CJ. Evidence for voltage modulation of IL-2 production in mitogen- stimulated human peripheral blood lymphocytes. JImmunol. 1992;149(12):3784–94.
[61]
Koo GC, Blake JT, Talento A, Nguyen M, Lin S, Sirotina A, et al. Blockade of the voltage-gated potassium channel Kv1.3 inhibits immune responses in vivo. JImmunol. 1997;158(11):5120–8.
[62]
Hess SD, Oortgiesen M, Cahalan MD. Calcium oscillations in human T and natural killer cells depend upon membrane potential and calcium influx. JImmunol. 1993;150:2620–33.
[63]
Han Z, Lu J, Liu Y, Davis B, Lee MS, Olson MA, et al. Small-Molecule Probes Targeting the Viral PPxY-Host Nedd4 Interface Block Egress of a Broad Range of RNA Viruses. J Virol. 2014;88(13):7294–306. doi: 10.1128/JVI.00591-14. pmid:24741084
[64]
Fuchs S, Rensing-Ehl A, Speckmann C, Bengsch B, Schmitt-Graeff A, Bondzio I, et al. Antiviral and regulatory T cell immunity in a patient with stromal interaction molecule 1 deficiency. JImmunol. 2012;188(3):1523–33. doi: 10.4049/jimmunol.1102507
[65]
Oh-Hora M, Yamashita M, Hogan PG, Sharma S, Lamperti E, Chung W, et al. Dual functions for the endoplasmic reticulum calcium sensors STIM1 and STIM2 in T cell activation and tolerance. Nat Immunol. 2008;9(4):432–43. doi: 10.1038/ni1574. pmid:18327260
[66]
Licata JM, Simpson-Holley M, Wright NT, Han Z, Paragas J, Harty RN. Overlapping motifs (PTAP and PPEY) within the Ebola virus VP40 protein function independently as late budding domains: involvement of host proteins TSG101 and VPS-4. J Virol. 2003;77(3):1812–9. pmid:12525615 doi: 10.1128/jvi.77.3.1812-1819.2003
[67]
Lu J, Qu Y, Liu Y, Jambusaria R, Han Z, Ruthel G, et al. Host IQGAP1 and Ebola virus VP40 interactions facilitate virus-like particle egress. J Virol. 2013;87(13):7777–80. doi: 10.1128/JVI.00470-13. pmid:23637409
Tomori O, Johnson KM, Kiley MP, Elliott LH. Standardization of a plaque assay for Lassa virus. Journal of medical virology. 1987;22(1):77–89. pmid:3585290 doi: 10.1002/jmv.1890220110
[70]
Bushar G, Sagripanti JL. Method for improving accuracy of virus titration: standardization of plaque assay for Junin virus. Journal of virological methods. 1990;30(1):99–107. pmid:1707890 doi: 10.1016/0166-0934(90)90047-j
